This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Source: Deloitte Combining these types of health data allows pharmaceuticalcompanies to understand a person’s health and genetic profile better, thereby improving the quality of healthcare products and services. Pharma companies deal with enormous amounts of health data. What Is Health Data Management?
Real-world evidence can also provide what happens to the patient throughout life when isolated data from the randomized clinical trial period cannot bring. Use of Real-World Evidence in PharmaceuticalCompanies. Viseven helps organizations gain real insight into the world from the point of care throughout the patient journey.
This marks a significant shift in patientcare, as it allows for more accurate diagnoses and a better understanding of which treatments are effective and which are not, compared to relying solely on occasional hospital visits. And when that data is as sensitive as medicalrecords, the security risks increase exponentially.
I remember going to this gala affair put out by the pharmaceuticalcompany in Chicago when this breakthrough new class of drug called ACE inhibitors, and Captopril was the first of the kind and, you know, that was that was a breakthrough, much less angiotensin blockers and all the new categories of antihypertensive so, so that was new.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content